Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 15.1660.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 15.16 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202515.16
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 15.16
-75.04
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,313.3 Cr -4.4% -11.1% -22.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,879.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹166,620.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,431.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,070.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹107,051.0 Cr 0.3% -1.3% -9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-4.4%

-11.1%

-22.5%

SENSEX

-5%

-9.6%

3.1%


You may also like the below Video Courses